Jia Hao Qiu
Corporate Officer/Principal bei Bioveda China Fund Ltd.
Profil
Jia Hao Qiu is currently working as a Principal at Bioveda China Fund Ltd.
He previously held positions as an Independent Director at Jaguar Animal Health, Inc. and Jaguar Health, Inc., as well as a Member-Supervisory Board at CARsgen Therapeutics Co. Ltd.
Mr. Qiu completed his undergraduate degree at Shanghai Jiao Tong University.
Aktive Positionen von Jia Hao Qiu
| Unternehmen | Position | Beginn |
|---|---|---|
| Bioveda China Fund Ltd. | Corporate Officer/Principal | 01.01.2010 |
Ehemalige bekannte Positionen von Jia Hao Qiu
| Unternehmen | Position | Ende |
|---|---|---|
CARsgen Therapeutics Co. Ltd.
 CARsgen Therapeutics Co. Ltd. BiotechnologyHealth Technology CARsgen Therapeutics Co., Ltd. develops an immunotherapy cancer treatment. It develops a novel cell-based immunotherapy using T-cells carrying chimeric antigen receptor technology for cancer treatment. The company was founded by ZongHai Li in 2014 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | - |
| JAGUAR HEALTH, INC. | Direktor/Vorstandsmitglied | - |
Jaguar Animal Health, Inc.
 Jaguar Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Jaguar Animal Health, Inc. engages in the development and commercialization of gastrointestinal products for companion and production animals. Its product, Canalevia, is the company's prescription drug product candidate for the treatment of various forms diarrhea in dogs. It also developed its non-prescription product, Neonorm Calf, which helps dairies and beef farms proactively retain fluid in calves. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Jia Hao Qiu
| Shanghai Jiao Tong University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| JAGUAR HEALTH, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Jaguar Animal Health, Inc.
Jaguar Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Jaguar Animal Health, Inc. engages in the development and commercialization of gastrointestinal products for companion and production animals. Its product, Canalevia, is the company's prescription drug product candidate for the treatment of various forms diarrhea in dogs. It also developed its non-prescription product, Neonorm Calf, which helps dairies and beef farms proactively retain fluid in calves. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
CARsgen Therapeutics Co. Ltd.
CARsgen Therapeutics Co. Ltd. BiotechnologyHealth Technology CARsgen Therapeutics Co., Ltd. develops an immunotherapy cancer treatment. It develops a novel cell-based immunotherapy using T-cells carrying chimeric antigen receptor technology for cancer treatment. The company was founded by ZongHai Li in 2014 and is headquartered in Shanghai, China. | Health Technology |
| Bioveda China Fund Ltd. |
